Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted ...

European Union approves Bayer’s Nubeq for patients with advanced prostate cancer: Berlin Tuesday, July 22, 2025, 11:00 Hrs [IST] The European Commission has granted marketing au ...

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen receptor axis have significantly delayed disease progression. However, drug ...

Studies on the NMR methodology for characterizing the structure of polymers and biopolymers based on the understanding of the NMR chemical shift/structure correlation using solution-state and ...

Inside each cell of the human body are proteins that control which genes are expressed at the right place and time. However, ...

Researchers have solved a mystery that has confounded scientists for 80 years: the crystal structure of the ...

In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a ...

To determine whether increased androgen receptor protein concentration has a causal role in the hormone sensitive-to-hormone refractory transition, we introduced epitope-tagged wild-type AR cDNA ...

Hormone therapy for prostate cancer is typically initiated using drugs that lower serum testosterone, often in combination with competitive androgen receptor antagonists.

According to Dr Sabia Mangat, sperm health depends on various factors which includes the quantity, movement and structure of the sperms - Obesity has an impact on the sperm quality, because fat ...